Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov;25(6):742-6.
doi: 10.1097/01.bor.0000434674.62644.02.

Update in juvenile myositis

Kiran Nistala  1 , Lucy R Wedderburn
Affiliations
Free PMC article
Review

Update in juvenile myositis

Kiran Nistala et al. Curr Opin Rheumatol. 2013 Nov.
Free PMC article

Abstract

Purpose of review: This update on childhood idiopathic inflammatory myopathies (IIMs) reviews recent progress in the field of translational science and clinical research over the past 12-18 months.

Recent findings: Several new studies, including results from the international genome-wide association study, point to abnormalities of the adaptive immune system in childhood IIMs. Circulating T-follicular helper cells promote plasma cell differentiation and have been found in high levels in juvenile dermatomyositis (JDM), which may account the frequency of autoantibodies seen in this disease. One of the latest to be identified in JDM targets the protein NXP-2 and is associated with an increased risk of calcinosis in young patients. The first randomized controlled clinical trial in refractory adult and childhood IIMs was reported this year. B-cell depletion with the anti-CD20 antibody, rituximab, failed to achieve its primary end point, but patients with JDM did show good improvement in disease activity. A new international definition of disease remission in JDM has been agreed, which will aid disease assessment in future therapeutic trials.

Summary: The challenges of studying a rare disease such as JDM have been overcome by several collaborative studies and have led to significant progress in understanding the cause, treatment and prognosis of childhood IIMs.

PubMed Disclaimer

Figures

Box 1
Box 1
no caption available
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Miller F, Cooper R, Vencovsky J, et al. Myositis Genetics Consortium. Genome-wide association study of dermatomyositis reveals shared genetic risk factors with other autoimmune diseases. Arthritis Rheum 2011; S656 - PMC - PubMed
    1. Chinoy H, Li CK, Platt H, et al. Genetic association study of NF-kappaB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 2012; 51:794–799 - PMC - PubMed
    1. Liu Y, Ramot Y, Torrelo A, et al. Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 2012; 64:895–907 - PMC - PubMed

    2. Defects in the immunoproteasome are found to cause myositis and infiltrative skin rashes, suggesting a new inflammatory pathway that may be relevant to JDM.

    1. Coley W, Rayavarapu S, Nagaraju K. Role of nonimmune mechanisms of muscle damage in idiopathic inflammatory myopathies. Arthritis Res Ther 2012; 14:209. - PMC - PubMed
    1. Shah M, Targoff IN, Rice MM, et al. Ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum 2013; 65:1934–1941 - PMC - PubMed

Publication types